- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, February 15, 2019
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
A study published in The American Journal of Managed Care® (AJMC®) was cited by RevCycle Intelligence. The researchers of the study, “Patients’ Views on Price Shopping and Price Transparency,” interviewed patients with access to a price transparency website and found that despite having a positive opinion of price shopping in theory, patients reported barriers to doing so in reality.
The National Pharmaceutical Council’s Wednesday CER Daily Newsfeed included 2 articles from AJMC® on curative therapies from the “Paying for Cures: Ensuring patient access and system sustainability” event. The article “Preparing Patients and the Health System for Curative Therapies in the Pipeline” covered a session where experts discussed how the healthcare system can pay for curative therapies that have high upfront costs with benefits that accrue over time. The article “Examining New Payment Ideas for Curative Therapies” sought to answer the question of how the health system can ensure that cutting-edge gene therapies and other curative therapies get to the patients that need them without leaving payers financially exposed.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
